Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ:: a nested case-control study

被引:256
|
作者
Ylitalo, N
Sorensen, P
Josefsson, AM
Magnusson, PKE
Andersen, PK
Pontén, J
Adami, HO
Gyllensten, UB
Melbye, M
机构
[1] Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden
[2] Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
[3] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden
[4] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
[5] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA
来源
LANCET | 2000年 / 355卷 / 9222期
关键词
D O I
10.1016/S0140-6736(00)02402-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Persistent infection with certain types of human papillomavirus (HPV) is believed to be a prerequisite for the development of cervical neoplasia. Persistence may depend on certain characteristics, such as viral load, which has so far been given little attention. We investigated the association between HPV 16 viral load and cervical carcinoma in situ. Methods We did a nested case-control study of women participating in cytological screening in Sweden. We used a sensitive quantitative PCR assay to estimate HPV 16 load in multiple smears for each woman, taken during a period of up to 26 years before diagnosis. We calculated C-t values, which decrease as the number of viral DNA copies increases. Findings 2081 smears from 478 cases and 1754 smears from 608 controls were tested. Among cases, we found a consistently increased load of HPV 16 already 13 years or more before diagnosis, and when many smears were still cytologically normal. Women with high HPV 16 viral loads were at least 30 times the relative risk of HPV-16-negative women more than a decade before diagnosis. The increase in relative risk was constant over time. About 25% of women (95% CI 0.12-0.32) infected with a high viral load before age 25 years developed cervical carcinoma in situ within 15 years. Interpretation Cervical carcinoma in situ associated with HPV 16 occurs mainly in HPV-16-positive women who have consistently high viral loads long term. Women at high risk could be identified by use of a quantitative HPV test in addition to cytological screening.
引用
收藏
页码:2194 / 2198
页数:5
相关论文
共 50 条
  • [41] Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study
    Colombara, Danny V.
    Manhart, Lisa E.
    Carter, Joseph J.
    Hawes, Stephen E.
    Weiss, Noel S.
    Hughes, James P.
    Barnett, Matt J.
    Goodman, Gary E.
    Smith, Jennifer S.
    Qiao, You-Lin
    Galloway, Denise A.
    CANCER CAUSES & CONTROL, 2015, 26 (12) : 1835 - 1844
  • [42] Specific Human Papillomavirus Types and Other Factors on the Risk of Cervical Intraepithelial Neoplasia A Case-Control Study in Korea
    Kim, Chan Joo
    Lee, Young Suk
    Kwack, Hyun Sung
    Yoon, Won Sik
    Park, Tae Chul
    Park, Jong-Sup
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (06) : 1067 - 1073
  • [43] Viral load of human papillomavirus and high-grade cervical intraepithelial neoplasia
    Wensveen, C. W. M.
    Beerman, H.
    Trimbos, J. B. M. Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 (01) : 56 - 57
  • [44] Human Papillomavirus Infection and Esophageal Squamous Cell Carcinoma: A Case-Control Study
    Guo, Fangcen
    Liu, Ying
    Wang, Xueqian
    He, Zhonghu
    Weiss, Noel S.
    Madeleine, Margaret M.
    Liu, Fangfang
    Tian, Xiuyun
    Song, Yuqin
    Pan, Yaqi
    Ning, Tao
    Yang, Haijun
    Shi, Xiaotian
    Lu, Changdong
    Cai, Hong
    Ke, Yang
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (05) : 780 - 785
  • [45] Prospective Study of HPV16 Viral Load and Risk of In Situ and Invasive Squamous Cervical Cancer
    Sundstrom, Karin
    Ploner, Alexander
    Dahlstrom, Lisen Arnheim
    Palmgren, Juni
    Dillner, Joakim
    Adami, Hans-Olov
    Ylitalo, Nathalie
    Sparen, Par
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (01) : 150 - 158
  • [46] Serum cholesterol and the risk of ductal carcinoma in situ:: a case-control study
    Elkhadrawy, TM
    Ahsan, H
    Neugut, AI
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 (05) : 393 - 396
  • [47] Role of parity and human papillomavirus in cervical cancer:: the IARC multicentric case-control study
    Muñoz, N
    Franceschi, S
    Bosetti, C
    Moreno, V
    Herrero, R
    Smith, JS
    Shah, KV
    Meijer, CJLM
    Bosch, FX
    LANCET, 2002, 359 (9312): : 1093 - 1101
  • [48] Human Papillomavirus Antibodies and Future Risk of Anogenital Cancer: A Nested Case-Control Study in the European Prospective Investigation Into Cancer and Nutrition Study
    Kreimer, Aimee R.
    Brennan, Paul
    Kuhs, Krystle A. Lang
    Waterboer, Tim
    Clifford, Gary
    Franceschi, Silvia
    Michel, Angelika
    Willhauck-Fleckenstein, Martina
    Riboli, Elio
    Castellsague, Xavier
    Hildesheim, Allan
    Fortner, Renee Turzanski
    Kaaks, Rudolf
    Palli, Domenico
    Ljuslinder, Ingrid
    Panico, Salvatore
    Clavel-Chapelon, Francoise
    Boutron-Ruault, Marie-Christine
    Mesrine, Sylvie
    Trichopoulou, Antonia
    Lagiou, Pagona
    Trichopoulos, Dimitrios
    Peeters, Petra H.
    Cross, Amanda J.
    Bueno-de-Mesquita, H. Bas
    Vineis, Paolo
    Larranaga, Nerea
    Pala, Valeria
    Sanchez, Maria-Jose
    Navarro, Carmen
    Barricarte, Aurelio
    Tumino, Rosario
    Khaw, Kay-Tee
    Wareham, Nicholas
    Boeing, Heiner
    Steffen, Annika
    Travis, Ruth C.
    Ramon Quiros, J.
    Weiderpass, Elisabete
    Pawlita, Michael
    Johansson, Mattias
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (08) : 877 - +
  • [49] Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study
    Janet E Flatley
    Alexandra Sargent
    Henry C Kitchener
    Jean M Russell
    Hilary J Powers
    BMC Cancer, 14
  • [50] Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study
    Flatley, Janet E.
    Sargent, Alexandra
    Kitchener, Henry C.
    Russell, Jean M.
    Powers, Hilary J.
    BMC CANCER, 2014, 14